61 related articles for article (PubMed ID: 20201088)
1. Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.
Wästerlid T; Brown PN; Hagberg O; Hagberg H; Pedersen LM; D'Amore F; Jerkeman M
Ann Oncol; 2013 Jul; 24(7):1879-1886. PubMed ID: 23446093
[TBL] [Abstract][Full Text] [Related]
2. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
Patte C; Auperin A; Gerrard M; Michon J; Pinkerton R; Sposto R; Weston C; Raphael M; Perkins SL; McCarthy K; Cairo MS;
Blood; 2007 Apr; 109(7):2773-80. PubMed ID: 17132719
[TBL] [Abstract][Full Text] [Related]
3. [The clinical characteristics and outcomes of 16 Burkitt' s lymphoma with testicular involvement].
Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Zhang YH
Zhonghua Xue Ye Xue Za Zhi; 2016 Sep; 37(9):768-773. PubMed ID: 27719719
[TBL] [Abstract][Full Text] [Related]
4. The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation.
Broccoli A; Argnani L; Gugliotta G; Pellegrini C; Casadei B; Bagnato G; Gentilini M; Stefoni V; Zinzani PL
Oncologist; 2024 Feb; ():. PubMed ID: 38339976
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Burkitt lymphoma with bone marrow involvement or Burkitt leukemia in Chinese children.
Zhu J; Zhen Z; Wang J; Sun F; Lu S; Huang J; Zhang Y; Sun X
Pediatr Investig; 2021 Jun; 5(2):112-117. PubMed ID: 34179707
[TBL] [Abstract][Full Text] [Related]
6. Early-stage Burkitt lymphoma remained in remission 7 years from diagnosis after only one cycle of chemoimmunotherapy.
Al Sbihi A; Manasrah N; Sano D; Lonardo S
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33879463
[TBL] [Abstract][Full Text] [Related]
7. Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients.
Jakobsen LH; Ellin F; Smeland KB; Wästerlid T; Christensen JH; Jørgensen JM; Josefsson PL; Øvlisen AK; Holte H; Blaker YN; Grauslund JH; Bjørn J; Molin D; Lagerlöf I; Smedby KE; Colvin K; Thanarajasingam G; Maurer MJ; Habermann TM; Song KW; Zhu KY; Gerrie AS; Cheah CY; El-Galaly TC
Br J Haematol; 2020 May; 189(4):661-671. PubMed ID: 32017050
[TBL] [Abstract][Full Text] [Related]
8. Metronomic Chemotherapy for Burkitt Lymphoma in a Patient With HIV: Case Report.
Dwivedi P; Kapse A; Bangurwar C; Tamhane A; Banavali S
J Pediatr Hematol Oncol; 2023 Mar; 45(2):78-81. PubMed ID: 36161878
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens.
Kelly JL; Toothaker SR; Ciminello L; Hoelzer D; Holte H; LaCasce AS; Mead G; Thomas D; Van Imhoff GW; Kahl BS; Cheson BD; Magrath IT; Fisher RI; Friedberg JW
Clin Lymphoma Myeloma; 2009 Aug; 9(4):307-10. PubMed ID: 19717381
[TBL] [Abstract][Full Text] [Related]
10. Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients.
Walczak P; Choquet S; Dantal J; Boutboul D; Suarez F; Baron M; Morel V; Cluzeau T; Touati M; Elias M; Bachy E; Nicolas-Virelizier E; Houot R; Venton G; Jacquet C; Moles-Moreau MP; Jardin F; Durot E; Balegroune N; Ecotiere L; Guieze R; Kamar N; Ysebaert L; Couzi L; Gonzalez H; Roulin L; Ou K; Caillard S; Zimmermann H; Trappe RU; Roos-Weil D
Haematologica; 2023 Oct; 108(10):2814-2819. PubMed ID: 36891749
[No Abstract] [Full Text] [Related]
11. Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features.
Zou H; Liu W; Wang Y; Shan D; Xie T; Li R; Liu H; Huang W; Fu M; Wang T; Lv R; Deng S; Sui W; Xu Y; Yi S; An G; Qiu L; Zou D
Chin Med J (Engl); 2023 Dec; ():. PubMed ID: 38061986
[No Abstract] [Full Text] [Related]
12. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases.
Perry AM; Crockett D; Dave BJ; Althof P; Winkler L; Smith LM; Aoun P; Chan WC; Fu K; Greiner TC; Bierman P; Gregory Bociek R; Vose JM; Armitage JO; Weisenburger DD
Br J Haematol; 2013 Jul; 162(1):40-9. PubMed ID: 23600716
[TBL] [Abstract][Full Text] [Related]
13. Status and prognostic nomogram of patients with Burkitt lymphoma.
Lu J; Tan H; Li B; Chen S; Xu L; Zou Y
Oncol Lett; 2020 Jan; 19(1):972-984. PubMed ID: 31897210
[TBL] [Abstract][Full Text] [Related]
14. Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
Oosten LEM; Chamuleau MED; Thielen FW; de Wreede LC; Siemes C; Doorduijn JK; Smeekes OS; Kersten MJ; Hardi L; Baars JW; Demandt AMP; Stevens WBC; Nijland M; van Imhoff GW; Brouwer R; Uyl-de Groot CA; Kluin PM; de Jong D; Veelken H
Ann Hematol; 2018 Feb; 97(2):255-266. PubMed ID: 29209924
[TBL] [Abstract][Full Text] [Related]
15. Burkitt lymphoma in adolescents and young adults: management challenges.
Dozzo M; Carobolante F; Donisi PM; Scattolin A; Maino E; Sancetta R; Viero P; Bassan R
Adolesc Health Med Ther; 2017; 8():11-29. PubMed ID: 28096698
[TBL] [Abstract][Full Text] [Related]
16. IGH amplification in patients with B cell lymphoma unclassifiable, with features intermediate between diffuse large B cell lymphoma and Burkitt's lymphoma.
Bellone M; Zaslav AL; Ahmed T; Lee HL; Ma Y; Hu Y
Biomark Res; 2014; 2():9. PubMed ID: 24891940
[TBL] [Abstract][Full Text] [Related]
17. Treatment of adolescents with aggressive B-cell malignancies: the pediatric experience.
Lange J; Burkhardt B
Curr Hematol Malig Rep; 2013 Sep; 8(3):226-35. PubMed ID: 23812872
[TBL] [Abstract][Full Text] [Related]
18. Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.
Tauro S; Cochrane L; Lauritzsen GF; Baker L; Delabie J; Roberts C; Mahendra P; Holte H
Am J Hematol; 2010 Apr; 85(4):261-3. PubMed ID: 20201088
[TBL] [Abstract][Full Text] [Related]
19. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
